📢 Congrats to our portfolio company, Proscia, a leader in pathology’s digital and AI transformation, on securing a $50M funding round led by Insight Partners, bringing their total funding to $130M! As cancer cases rise and the pathologist workforce shrinks, the demand for digital innovation in healthcare has never been greater. Proscia is revolutionizing pathology to accelerate the development of targeted therapies, improve diagnostic precision, and match more patients with the most effective treatments. Their AI-powered Concentriq platform is driving this shift, seamlessly connecting diagnostic labs, pharmaceutical companies, and life sciences organizations to transform the impact of pathology on patient care. With this new funding, Proscia will expand its customer base, enhance its AI capabilities, and continue scaling the platform - empowering pathologists and researchers to deliver faster, more accurate diagnoses and accelerate drug discovery. A huge congratulations to CEO David West and the entire Proscia team! We are excited to watch their continued impact on the future of precision medicine. 🚀 Read more here: https://lnkd.in/eK9vVXvD #DigitalHealth #AI #PrecisionMedicine #Pathology
Hitachi Ventures, Congrats to Proscia on this amazing milestone! It’s exciting to see how their work in AI and digital pathology is making such a difference in patient care. Looking forward to seeing how they expand and innovate even more. What new features are you most excited about? 🚀👏 #HealthcareInnovation #AIinMedicine